Charles Schwab Investment Management Inc Astrazeneca PLC Transaction History

Charles Schwab Investment Management Inc

  • $521 Billion
  • Q1 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 250,227 shares of AZN stock, worth $17.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250,227
Previous 1,744,081 85.65%
Holding current value
$17.6 Million
Previous $114 Million 83.91%
% of portfolio
0.0%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$65.37 - $77.96 $97.7 Million - $116 Million
-1,493,854 Reduced 85.65%
250,227 $18.4 Million
Q4 2024

Feb 06, 2025
SELL
$63.2 - $79.58 $2.54 Million - $3.2 Million
-40,154 Reduced 2.25%
1,744,081 $114 Million
Q3 2024

Nov 12, 2024
BUY
$76.67 - $87.62 $676,996 - $773,684
8,830 Added 0.5%
1,784,235 $139 Million
Q2 2024

Aug 12, 2024
BUY
$66.81 - $80.83 $111 Million - $135 Million
1,666,500 Added 1530.23%
1,775,405 $138 Million
Q1 2024

May 08, 2024
SELL
$61.03 - $69.57 $2.34 Million - $2.67 Million
-38,346 Reduced 26.04%
108,905 $7.38 Million
Q4 2023

Feb 06, 2024
BUY
$61.89 - $69.28 $1.5 Million - $1.68 Million
24,233 Added 19.7%
147,251 $9.92 Million
Q3 2023

Nov 08, 2023
BUY
$64.85 - $71.7 $5.62 Million - $6.21 Million
86,610 Added 237.89%
123,018 $8.33 Million
Q2 2023

Aug 09, 2023
BUY
$69.91 - $75.81 $1.17 Million - $1.27 Million
16,736 Added 85.08%
36,408 $2.61 Million
Q1 2023

May 11, 2023
BUY
$63.15 - $71.6 $455,753 - $516,737
7,217 Added 57.94%
19,672 $1.37 Million
Q4 2022

Feb 13, 2023
BUY
$54.21 - $70.44 $675,185 - $877,330
12,455 New
12,455 $844,000
Q1 2021

May 17, 2021
SELL
$47.16 - $54.44 $1.7 Million - $1.97 Million
-36,100 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$48.52 - $58.02 $10.1 Million - $12.1 Million
-208,900 Reduced 85.27%
36,100 $1.81 Million
Q3 2020

Nov 13, 2020
SELL
$53.07 - $61.1 $3.93 Million - $4.52 Million
-74,000 Reduced 23.2%
245,000 $13.4 Million
Q2 2020

Aug 14, 2020
SELL
$43.1 - $55.31 $7.49 Million - $9.61 Million
-173,700 Reduced 35.25%
319,000 $16.9 Million
Q1 2020

May 15, 2020
SELL
$37.79 - $51.33 $6.19 Million - $8.41 Million
-163,800 Reduced 24.95%
492,700 $22 Million
Q4 2019

Feb 07, 2020
SELL
$42.46 - $50.46 $7.79 Million - $9.26 Million
-183,500 Reduced 21.85%
656,500 $32.7 Million
Q1 2019

May 14, 2019
BUY
$35.49 - $43.02 $29.8 Million - $36.1 Million
840,000 New
840,000 $34 Million

Others Institutions Holding AZN

# of Institutions
1,428
Shares Held
504M
Call Options Held
10M
Put Options Held
3.14M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $218B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email